Jiangsu Hengrui Medicine
600276.SS
#471
Rank
S$68.88 B
Marketcap
S$10.38
Share price
1.79%
Change (1 day)
11.76%
Change (1 year)
Jiangsu Hengrui Medicine Company Limited is a Chinese pharmaceutical company engaged in the R&D, manufacturing and sales of healthcare products, including antineoplastic drugs, angiomyocardiac drugs, drugs for surgery, contrast agents and antibiotics

Quarterly Reports

Thumbnail Jiangsu Hengrui Medicine
 Quarterly Report 2025-q3

Quarterly Report 2025-q3

Language: Chinese

View Quarterly Report